Cardiovascular disease is the leading cause of death worldwide. Molecular imaging with targeted tracers by positron emission tomography (PET) allows for the noninvasive detection and characterization of biological changes at the molecular level, leading to earlier disease detection, objective monitoring of therapies, and better prognostication of cardiovascular diseases progression. Here we review, the current role of PET in cardiovascular disease, with emphasize on tracers developed for PET imaging of cardiovascular diseases
Atherosclerosis is characterized by the formation of complex atheroma lesions (plaques) in arteries ...
Molecular imaging seeks to unravel critical molecular and cellular events in living subjects by prov...
Cardiovascular diseases (CVDs), including atherosclerosis, are chronic inflammatory diseases charact...
Copyright © 2014 Yesen Li et al.This is an open access article distributed under the Creative Common...
Positron emission tomography (PET) has been successfully applied to an increasing number of cardiova...
Cardiovascular diseases (CVD) is a collective term describing a range of conditions that affect the ...
With advances in scanner technology, postprocessing techniques, and the development of novel positro...
PET imaging is able to harness biological processes to characterise high-risk features of atheroscle...
Positron emission tomography (PET) is a powerful, quantitative imaging modality that has been used f...
Despite significant advancements in medical and device-based therapies, cardiovascular disease remai...
Studies using arginine-glycine-aspartate (RGD)-PET agents in cardiovascular diseases have been recen...
Cardiovascular disease is the major cause of morbidity and mortality in developed countries and athe...
Cardiovascular disease due to atherosclerosis is still the main cause of morbidity and mortality wor...
Advancements in molecular medicine technology have allowed the development of innovative and better ...
Cardiovascular disease (CVD) is the leading cause of death and disease burden worldwide. Nuclear myo...
Atherosclerosis is characterized by the formation of complex atheroma lesions (plaques) in arteries ...
Molecular imaging seeks to unravel critical molecular and cellular events in living subjects by prov...
Cardiovascular diseases (CVDs), including atherosclerosis, are chronic inflammatory diseases charact...
Copyright © 2014 Yesen Li et al.This is an open access article distributed under the Creative Common...
Positron emission tomography (PET) has been successfully applied to an increasing number of cardiova...
Cardiovascular diseases (CVD) is a collective term describing a range of conditions that affect the ...
With advances in scanner technology, postprocessing techniques, and the development of novel positro...
PET imaging is able to harness biological processes to characterise high-risk features of atheroscle...
Positron emission tomography (PET) is a powerful, quantitative imaging modality that has been used f...
Despite significant advancements in medical and device-based therapies, cardiovascular disease remai...
Studies using arginine-glycine-aspartate (RGD)-PET agents in cardiovascular diseases have been recen...
Cardiovascular disease is the major cause of morbidity and mortality in developed countries and athe...
Cardiovascular disease due to atherosclerosis is still the main cause of morbidity and mortality wor...
Advancements in molecular medicine technology have allowed the development of innovative and better ...
Cardiovascular disease (CVD) is the leading cause of death and disease burden worldwide. Nuclear myo...
Atherosclerosis is characterized by the formation of complex atheroma lesions (plaques) in arteries ...
Molecular imaging seeks to unravel critical molecular and cellular events in living subjects by prov...
Cardiovascular diseases (CVDs), including atherosclerosis, are chronic inflammatory diseases charact...